A recent genomic study of 124 childhood hypodiploid ALL cases revealed recurrent mutations in receptor tyrosine kinase and Ras signaling pathways as well as in the IKZF3 gene in near-haploid ALL, and implicated PI3K inhibition as a potential treatment strategy [4]. The gene discussed is IKZF3; the disease is acute lymphoblastic leukemia.